Frozen, Non-UK Derived Pathogen Reduced Plasma

Descriptions

NHSBT requires pathogen reduced plasma which will then be subsequently manufactured into FFP, Single and pooled cryoprecipitate for paediatric and neonatal use, for recipients born on / after 1.1.1996. Those recipients are deemed not to have been exposed to the risk of vCJD in the UK food chain. Plasma is to be sourced from a TPSG approved (based on SaBTOs 2013 recommendations) country outside the UK with vCJD prevalence >2,5 log lower than the UK.The Contract commenced on the 8.5.2018, the term of this Contract shall expire 2 years from the end of the Set Up Period and Ramp Up Period 1.12.2018 (estimated). The contract is for a period of 2 years with the option to extend for 2 periods of 12 months.The estimated value given below is based on 4 years.